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OBJECTIVE — Arterial stiffness occurs early in the atherosclerotic process; however, few
data are available concerning risk factors for arterial stiffness in youth with diabetes. We iden-
tiﬁed factors associated with arterial stiffness in youth with diabetes and assessed the effects of
these factors on the relationship between arterial stiffness and diabetes type (type 1 vs. type 2).
RESEARCH DESIGN AND METHODS — A subset of patients from the SEARCH for
Diabetes in Youth study with type 1 (n  535) and type 2 diabetes (n  60), aged 10–23 years
(52% male; 82% non-Hispanic white; diabetes duration 65  49 months) had arterial stiffness,
anthropometrics, blood pressure, fasting lipids, and A1C measured. Arterial stiffness was mea-
sured by brachial distensibility (brachD), pulse wave velocity (PWV), and augmentation index
adjusted to heart rate of 75 beats/min (AI75).
RESULTS — Youth with type 2 diabetes had worse brachD (5.2  0.9 vs. 6.1  1.2%/
mmHg), PWV (6.4  1.3 vs. 5.3  0.8 m/s), and AI75 (6.4  9.9 vs. 2.2  10.2%) than those
with type 1 diabetes (P  0.01 for each). These differences were largely mediated through
increased central adiposity and higher blood pressure in youth with type 2 diabetes. We also
found a pattern of association of arterial stiffness measures with waist circumference and blood
pressure, independent of diabetes type.
CONCLUSIONS — Youth with type 2 diabetes have worse arterial stiffness than similar
youth with type 1 diabetes. Increased central adiposity and blood pressure are associated with
measures of arterial stiffness, independent of diabetes type. Whether these ﬁndings indicate that
youth with type 2 diabetes will be at higher risk for future complications requires longitudinal
studies.
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A
dults with type 1 or type 2 diabetes
are at greater risk for developing
cardiovascular disease (CVD) than
the general population (1). Nevertheless,
the process of atherosclerosis is known to
begininchildhood(1,2).Whereasmostpe-
diatric diabetes studies have focused on
youth with type 1 diabetes, data are now
emerging to show that the burden of diabe-
tes-related complications among adoles-
cents with type 2 diabetes is at least as high
as that for those with type 1 diabetes (3).
Vascular dysfunction occurs early in
the atherosclerotic process and is associ-
ated with obesity and insulin resistance
(4). Multiple methods have been devel-
oped to evaluate vascular function nonin-
vasively, including several measures of
arterial stiffness, such as brachial disten-
sibility, pulse wave velocity (PWV), and
augmentation index (5). Because athero-
sclerosis develops in a nonuniform fash-
ion (6), multiple measures are needed in
any noninvasive study of early CVD in
youth.
The aim of this report was to identify
factors associated with measures of arte-
rialstiffnessinyouthwithdiabetespartic-
ipating in the SEARCH for Diabetes in
Youth (SEARCH) study and to assess the
effect of these factors on the relationship
between arterial stiffness and diabetes
type (type 1 vs. type 2).
RESEARCH DESIGN AND
METHODS— SEARCH is a multi-
center study that began conducting pop-
ulation-based ascertainment of cases of
diabetes in youth 20 years of age in
2001 and continues through the present.
A detailed description of SEARCH study
methodshasbeenpublished(7).Thecase
ascertainment approach involves net-
works of pediatric and adult endocri-
nologists,existingpediatricdiabetesdata-
bases, hospitals, health plan databases,
and other health care organizations.
From two of the six SEARCH study sites
(Colorado and Ohio), 602 SEARCH
participants were recruited between
September 2004 and October 2005 to
participate in a substudy to examine de-
terminants of arterial stiffness. Eligibil-
ity criteria included age at study visit
10 years; diabetes duration 9
months; and participation in an in-
person SEARCH research visit.
The study was reviewed and ap-
proved by local institutional review
boards. Informed consent and assent,
where applicable, were obtained from all
subjects and parents/guardians of sub-
jects aged 18 years before enrollment.
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Youth with diabetes or their parent/
guardians completed an initial survey on
demographic and diabetes-related fac-
tors.Diabetestypewasreportedbyhealth
care professionals or abstracted from
medical records. For this report, we have
restricted analyses to youth with type 1
and type 2 diabetes. Provider-based deﬁ-
nitions of type 1 and type 2 diabetes were
consistent with clinical and biochemical
characteristics of diabetes type, including
the presence of diabetes autoantibodies
andresidualinsulinsecretion.Youthwith
maturity-onset diabetes of the young, hy-
brid, other, or missing type were ex-
cluded (n  7).
Blood was drawn after an overnight
fast, under conditions of metabolic stabil-
ity, to measure A1C, fasting glucose, and
lipids (total, HDL, and LDL cholesterol
and triglycerides). Speciﬁc methods for
these tests have been described previ-
ously (7,8). A brief physical examination
included height, weight, waist circumfer-
ence, and systolic (SBP) and diastolic
blood pressure (DBP). Weight and height
were compared with 2000 Centers for
DiseaseControlandPreventionstandards
fortheU.S.tocalculatenormalizedBMIZ
scores.
Arterial stiffness measures
Threearterialstiffnessmeasureswereper-
formed after 5 min of rest: 1) brachial ar-
tery distensibility (brachD); 2) PWV in
the carotid to femoral segment; and 3)
augmentationindexadjustedtoheartrate
of 75 beats/min (AI75).
Vascular function testing was per-
formed using a DynaPulse Pathway in-
strument (Pulse Metric, San Diego, CA),
which derives brachD using pulse dy-
namic analysis of arterial pressure signals
obtained from a standard cuff sphygmo-
manometer (9). The pressure waveform
was calibrated and incorporated into a
physical model of the cardiovascular sys-
tem, assuming a straight tube brachial ar-
teryandT-tubeaorticsystem.BrachDwas
calculatedusinganempiricalmodeltoes-
timate baseline brachial artery diameter
from sex, height, weight, and mean arte-
rial pressure (MAP). Lower brachD indi-
cates increased arterial stiffness. A blood
pressure cuff appropriate for the subject’s
arm size was applied. Three automatic
blood pressure recordings of SBP, DBP,
MAP, and heart rate were obtained. Off-
line analyses of brachial artery pressure
curvedatawerethenperformedbyPulse
Metric, using an automated system to
deriveparametersfromthepulsecurves
to calculate brachD (5).
PWV calculates the speed for the
pressure wave generated by cardiac ejec-
tion to reach the periphery. Higher PWV
indicatesincreasedarterialstiffness.PWV
was measured with a SphygmoCor Vx
System (AtCor Medical, Sydney, Austra-
lia). Three electrocardiogram leads were
applied to the torso, and the average of
three distances from the lowest portion of
the sternal notch to the carotid and fem-
oralarterysiteswasobtained(10).Apres-
sure waveform was obtained for the
proximal site (carotid) and a second was
recorded from the femoral artery. Wave-
forms were gated by the R wave on the
simultaneously recorded electrocardio-
gram. PWV is the difference in the carot-
id-to-femoral path length divided by the
difference in R wave–to–waveform foot
times,usinganaverageofatleast10beats
to cover a complete respiratory cycle. The
average of three recordings of PWV was
used in the analyses.
The augmentation index (AIx) pro-
vides a measure of systemic arterial
stiffness (11). A higher AIx indicates in-
creased arterial stiffness. The Sphygmo-
Cor tonometer was placed over the right
radial artery, and data were collected as
described previously (12). The pressure
waves were calibrated using MAP and
DBPobtainedinthesamearm.Thedevice
then analyzed the pulse wave using a val-
idated generalized transfer function.
Wave forms collected over a 10-s period
were averaged to produce peripheral and
corresponding central (ascending aortic)
pressure waveforms. Ascending aortic
pressure and AIx were derived from the
central pressure waveform. The AIx was
calculated as the difference between the
main outgoing wave and the reﬂected
wave of the central arterial waveform, ex-
pressed as a percentage of the central
pulse pressure. Because AIx is affected by
heart rate, values were adjusted to a stan-
dardheartrateof75beats/min(AI75).An
average of three measures was used in the
analyses.
Statistical analyses
Statistical analyses were performed using
SAS software (version 9.1; SAS Institute,
Cary, NC). Comparisons of demographic
and clinical characteristics according to
diabetes type were examined using 
2
tests for categorical variables, t tests for
normally distributed continuous vari-
ables,andKruskal-Wallistestsforcontin-
uous variables with skewed distributions
(Table 1). Sequential multiple linear re-
gressions were performed to examine the
association of diabetes type (type 2 vs.
type 1) with each arterial stiffness mea-
sure and the effect of adjustment for
covariates on this relationship. Demo-
graphic and metabolic variables associ-
ated with at least one measure of arterial
stiffness at P  0.05 were considered for
inclusion in the multivariate models.
Variables examined but not included in
themodelsincludeBMIZscore,totalcho-
lesterol, triglycerides, and albuminuria.
Covariatesenteredintosequentialmodels
are shown in Table 2. In these models we
examinedwhetherthehypothesizedasso-
ciation between diabetes type (type 2 vs.
type 1) and measures of arterial stiffness
was explained by the addition of a partic-
ular (set of) risk factors (Table 3). In ad-
dition, in model 7 we examined which of
the above variables were independently
associated with measures of arterial stiff-
ness (Table 4).
RESULTS— Clinical characteristics of
study participants are given in Table 1,
according to diabetes type. Of 595 sub-
jects, 90% had type 1 diabetes and 10%
had type 2 diabetes. The cohort included
52% male participants and 82% non-
Hispanic whites and had a mean  SD
duration of diabetes of 65  49 months
andageof14.93.4years.Subjectswith
type 2 diabetes were slightly older, were
more ethnically diverse, had higher BMI
and BMI Z scores, and had lower A1C
than subjects with type 1 diabetes. Table
1 also shows that youth with type 2 dia-
betes had worse measures of arterial stiff-
ness (lower brachD and higher AI75 and
PWV) (P  0.01 for all).
Table 2 shows bivariate associations
between risk factors of interest and mea-
sures of arterial stiffness (brachD, PVW,
and AI75), stratiﬁed by diabetes type. As-
sociations were similar for youth with
type 1 and type 2 diabetes across several
measures of arterial stiffness for waist cir-
cumference and blood pressure (espe-
cially systolic), whereas A1C and lipids
(HDL and LDL cholesterol) tended to be
associated with measures of arterial stiff-
ness only in youth with type 1 diabetes.
Table 3 presents the association be-
tween each measure of arterial stiffness
and diabetes type (type 2 vs. type 1) in
sequential multiple linear regressions
models. Of note, brachD and PWV mea-
sures already take into account the height
or length of the vascular segment being
studied. Addition of height to any of the
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niﬁcantly alter the relationship between
diabetes type and these arterial stiffness
measures. Regression models for AI75 in-
cluded adjustment for subjects’ height.
After adjustment for age, sex, race/
ethnicity, study site, and diabetes duration,
type 2 diabetes status was signiﬁcantly as-
sociated with lower brachD, higher PWV,
and AI75 (Table 3, model 1). On addi-
tional adjustment for A1C, associations
were virtually unchanged (model 2). On
additional adjustment for differences in
waist circumference (model 3), type 2 di-
abetes status was no longer signiﬁcantly
associated with brachD and PWV, al-
though AI75 still remained signiﬁcantly
higher in participants with type 2 diabe-
tes. In the following three models, we ex-
plored whether adjustment for lipids
(HDL cholesterol and LDL cholesterol,
model4),SBP(model5),andDBP(model
6), in addition to A1C and demographic
factors, inﬂuenced the associations of in-
terest. Whereas addition of lipid levels
had no substantial impact, addition of
SBP and, to a lesser extent, addition of
DBP removed differences in brachD and
AI75, but not differences in PWV be-
tween youth with type 2 and type 1 dia-
betes. Finally, adjustment for all potential
risk factors in model 7 virtually removed
all differences in measures of arterial stiff-
ness according to diabetes status. Adjust-
ment for pulse pressure instead of SBP
and DBP in a model including all other
covariates (model 8) had an effect on the
relationship between arterial stiffness
measuresanddiabetestypesimilartothat
of blood pressure levels.
Table 4 shows  coefﬁcients and cor-
responding P values for associations be-
tween each measure of arterial stiffness
and all covariates included in model 7. In
this model, lower brachD was indepen-
dently associated with higher waist cir-
cumference, SBP, and DBP; increased
PWV was associated with older age,
higherwaistcircumference,andDBP;and
increased AI75 was associated with fe-
male sex, minority racial/ethnic back-
ground, longer diabetes duration, higher
LDL cholesterol, and DBP. No measure of
arterial stiffness was associated with A1C
in multivariate models.
CONCLUSIONS — Our data indi-
cate that youth with type 2 diabetes have
signiﬁcantly worse arterial stiffness mea-
sures than similar youth with type 1
diabetes. These differences are not ac-
counted for by differences in demo-
graphiccharacteristics(age,sex,andrace/
ethnicity), diabetes duration, and A1C
Table 1—Clinical characteristics of study participants according to diabetes type
Type 1 diabetes Type 2 diabetes P
n 535 60
Sex (% male)* 285 (53) 24 (40) 0.05
Race/ethnicity* 0.0001
Non-Hispanic white 466 (87) 20 (33)
African American 27 (5) 22 (37)
Hispanic 27 (5) 16 (27)
Other 15 (3) 2 (3)
Age at CVD visit (years) 14.6  3.3 17.4  2.7 0.0001
Duration of diabetes (years)† 4.8 (2.4–8.0) 3.1 (2.1–4.5) 0.0001
A1C (%)‡ 8.3  1.5 7.5  2.7 0.04
Height (cm)‡ 162.5  12.6 168.1  12.7 0.001
Weight (kg)‡ 60.2  17.3 95.9  29.1 0.0001
BMI (kg/m
2)‡ 22.4  4.5 33.6  8.7 0.0001
BMI Z score‡ 0.6  0.9 1.7  0.9 0.0001
Waist circumference (cm)‡ 76.2  11.9 103.9  18.5 0.0001
Total cholesterol (mg/dl)‡ 169  32 171  35 0.7
LDL cholesterol (mg/dl)‡ 100  26 105  30 0.14
HDL cholesterol (mg/dl)‡ 55  12 42  10 0.0001
Triglycerides (mg/dl)† 64 (48–89) 99 (72–147) 0.0001
SBP (mmHg)‡ 117  11 125  11 0.0001
DBP (mmHg)‡ 68  77 3  8 0.0001
Pulse pressure (mmHg)‡ 49  85 2  8 0.001
Albuminuria (%)* 11.2 10.0 0.80
BrachD (%/mmHg)‡ 6.1  1.2 5.2  0.9 0.0001
PWV (m/s)‡ 5.3  0.8 6.4  1.3 0.0001
AI75 (%)‡ 2.2  10.2 6.4  9.9 0.003
Data are n (%), means  SD, or medians (interquartile range). BMI Z score was standardized by age and sex
per Centers for Disease Control and Prevention growth charts; waist circumference was measured per
National Health and Nutrition Examination Survey III; duration of diabetes indicates duration of diabetes at
the time of the CVD visit. *P value from 
2 test. †P value from Kruskal-Wallis test. ‡P value from t test.
Table 2—Univariate associations of measures of arterial stiffness by diabetes status
Arterial stiffness measure
BrachD PWV AI75
Type 1 diabetes Type 2 diabetes Type 1 diabetes Type 2 diabetes Type 1 diabetes Type 2 diabetes
Age (years) 0.43  0.08* 0.09  0.24 0.67  0.05* 1.15  0.28† 2.21  0.67† 4.47  2.30
A1C 0.04  0.02 0.01  0.05 0.08  0.02† 0.02  0.06 0.50  0.30 0.16  0.47
Waist circumference 0.19  0.02* 0.15  0.03* 0.16  0.01* 0.15  0.04† 0.51  0.19† 0.14  0.36
LDL cholesterol 0.01  0.01 0.02  0.02 0.02  0.01† 0.02  0.03 0.32  0.09† 0.26  0.22
HDL cholesterol 0.05  0.02 0.01  0.07 0.05  0.02† 0.13  0.09 0.39  0.18 0.007  0.66
SBP 0.33  0.02* 0.15  0.06† 0.17  0.02* 0.26  0.07† 0.45  0.22 0.47  0.61
DBP 0.10  0.04 0.005  0.079 0.30  0.02* 0.48  0.08* 0.89  0.32† 2.66  0.74†
Data are  coefﬁcients  SEM. A1C is per 1 unit change; all other continuous measures are per 5 units change. Signiﬁcant associations (P  0.05) are in bold. *P 
0.0001. †P  0.01.
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creased central adiposity and higher
bloodpressurelevelsinyouthwithtype2
diabetes. We also found a pattern of asso-
ciation of arterial stiffness measures with
central adiposity (waist circumference)
and blood pressure, independent of dia-
betes type. Thus, worse patterns of arte-
rial stiffness seen in youth with type 2
diabetes are probably due to the higher
prevalence of CVD risk factors seen in
such subjects. The presence of CVD risk
factors including hypertension, obesity,
and subclinical hyperglycemia may
contribute to vascular change before di-
agnosis of diabetes for patients with
both type 1 and type 2 diabetes, al-
though given the relatively acute onset
of type 1 diabetes, this is more likely to
occur in patients with type 2 diabetes.
These results suggest that increased
adiposity may contribute to increased ar-
terial stiffness in youth with diabetes, re-
gardless of diabetes type. Other studies
have also found a relationship between
body size and vascular function in adults
(13,14) and youth with type 2 diabetes
(15), but data in youth with type 1 diabe-
tes are limited (16). Prevention and con-
trolofobesityinyouthwithbothdiabetes
types may therefore play a signiﬁcant role
in reducing the risk of early vascular
changes.
Blood pressure was also a signiﬁcant
independent correlate in our analyses,
which is consistent with previous studies
of arterial stiffness in adults. Evidence
from such studies suggests that subclini-
cal changes in blood pressure may have
an impact on arterial stiffness before hy-
pertension is clinically evident (5,17).
We did not observe a cross-sectional
association between glycemic control
(A1C) and arterial stiffness in this study.
Our data are similar to previous publica-
tions regarding the relationship between
A1C and AIx in younger type 1 diabetic
patients (18). There are several possible
explanations for this ﬁnding. First, our
data only explore cross-sectional associa-
tions between a single A1C measure and
Table3—Associationbetweendiabetestype(type2vs.type1diabetes)andmeasuresofarterialstiffnessinmultiplelinearregressionanalysis
BrachD PWV AI75*
 P  P  P
Model 1: diabetes type, age, race, sex, site,
and duration 0.57  0.20 0.004 0.62  0.12 0.0001 4.27  1.47 0.004
Model 2: model 1  A1C 0.51  0.20 0.01 0.67  0.13 0.0001 4.53  1.51 0.003
Model 3: model 1  A1C  waist
circumference 0.13  0.21 0.51 0.24  0.13 0.07 3.59  1.69 0.03
Model 4: model 1  A1C  LDL cholesterol,
HDL cholesterol 0.45  0.21 0.04 0.57  0.13 0.0001 3.73  1.58 0.02
Model 5: model 1  A1C  SBP 0.25  0.17 0.15 0.45  0.13 0.0004 2.57  1.61 0.11
Model 6: model 1  A1C  DBP 0.50  0.20 0.01 0.45  0.12 0.0002 2.23  1.57 0.16
Model 7: model 1  A1C  waist  LDL
cholesterol, HDL cholesterol  SBP and
DBP 0.01  0.16 0. 0.15  0.13 0.23 1.75  1.74 0.31
Model 8: model 2  waist  LDL
cholesterol, HDL cholesterol  pulse
pressure 0.01  0.16 0.93 0.14  0.14 0.32 1.74  1.78 0.33
Data are  coefﬁcients  SEM.  coefﬁcients represent the differences in BrachD, PWV, and AI75 in subjects with type 2 diabetes compared with those with type
1 diabetes when adjusting for the variables included in the regression model. *Regression models for AI75 include an adjustment for height.
Table 4—Determinants of arterial stiffness measures in multiple linear regression analysis
Arterial stiffness measure
BrachD PWV AI75*
Diabetes type (type 2 vs. type 1) 0.01  0.16 (0.9) 0.15  0.13 (0.2) 1.75  1.74 (0.3)
Age at visit 0.03  0.07 (0.6) 0.29  0.06 (<0.0001) 0.66  0.88 (0.4)
Sex (female vs. male) 0.14  0.07 (0.05) 0.05  0.06 (0.3) 1.93  0.85 (0.02)
Race (other vs. non-Hispanic white) 0.15  0.10 (0.1) 0.01  0.08 (0.9) 2.94  1.12 (0.01)
Duration of diabetes 0.07  0.05 (0.1) 0.07  0.04 (0.09) 1.24  0.55 (0.02)
A1C 0.0004  0.02 (0.9) 0.01  0.02 (0.5) 0.06  0.24 (0.8)
Waist circumference 0.08  0.02 (<0.0001) 0.07  0.01 (<0.0001) 0.0003  0.20 (0.9)
LDL cholesterol 0.002  0.01 (0.7) 0.005  0.01 (0.3) 0.17  0.08 (0.03)
HDL cholesterol 0.005  0.02 (0.7) 0.01  0.01 (0.3) 0.04  0.17 (0.8)
SBP 0.52  0.03 (<0.0001) 0.02  0.02 (0.4) 0.48  0.28 (0.09)
DBP 0.51  0.03 (<0.0001) 0.20  0.03 (<0.0001) 1.94  0.39 (<0.0001)
R
2 0.5675 0.5263 0.3118
DataarecoefﬁcientsSEM(Pvalues).A1Cisper1unitchange;allothercontinuousmeasuresareper5unitschange.Signiﬁcantassociationsareinbold.*Model
for AI75 includes adjustment for height ( 0.28  0.04, P  0.0001).
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vascular changes in diabetic youth may
provide further insight into how long-
term glycemic control may affect arterial
stiffness, even before clinical onset of
chronic vascular complications. Second,
theeffectsofhyperglycemiaonthevascu-
lature may not be seen with measures of
arterial stiffness. However, studies of ca-
rotid intima-media thickness (cIMT) in
youth with type 1 diabetes also did not
show an association with A1C (19). Hy-
perglycemia might not affect vascular
structureandfunctionmeasurablyinper-
sons with a relatively short duration of
diabetes. In our cohort, the median (in-
terquartile range) duration of diabetes
was 4.75 (2.42–8.00) and 3.13 (2.08–
4.54) years for patients with type 1 and
type 2 diabetes, respectively. Parikh et al.
(20)notedanassociationbetweencarotid
distensibility and A1C in a cohort of ado-
lescents with type 1 diabetes (aged 15.8
years) with longer diabetes duration (9.3
years).Worseglycemiccontrolduringthe
Diabetes Control and Complications
Trial (DCCT) was associated with in-
creased progression of cIMT (21) and a
higher incidence of CVD events in the
Epidemiology of Diabetes Interventions
and Complications (EDIC) study (22).
However, the DCCT ﬁndings were ob-
served in older subjects (mean age 35
years) with longer diabetes duration
(mean duration 13.8 years).
To our knowledge, this is the ﬁrst
study to compare measurements of arte-
rialstiffnessinyouthwithtype1andtype
2 diabetes. The cohort of 595 subjects is
relatively large. Other studies of arterial
stiffness(18,20)andcIMT(19)havebeen
conducted in smaller cohorts of youth
withtype1diabetes.Moreover,ourstudy
includedmultiplemethodstoevaluatear-
terial stiffness (brachD, PWV, and AI75)
andshowedconsistentresultsacrossallof
these measures. Of the methods used in
this study, PWV appeared to be the most
robust. PWV was signiﬁcantly higher in
youth with type 2 diabetes even after ad-
justment for SBP and DBP, whereas dif-
ferences in brachD and AI75 by diabetes
type seemed to be more sensitive to ad-
justments for blood pressure.
Our study has limitations. A nondia-
betic control group was not included,
thus limiting our ability to compare these
diabetic patients with the general popula-
tion of healthy youth. Of note, data are
sparse among nondiabetic youth of simi-
lar age (11,18,23). Data were collected in
only 60 subjects with type 2 diabetes.
However, this relatively small sample is
representativeofyouthwithtype2diabe-
tes participating in the larger SEARCH
study (24), and only Urbina et al. (25)
have reported on arterial stiffness in a
larger cohort of youth with type 2 diabe-
tes; however, PWV and AI75 were not in-
cluded in that study.
Apotentialmethodologicallimitation
for PWV is the distance measured exter-
nally on the body from the suprasternal
notch to the femoral pulse. If the distance
is longer for subjects with larger waist cir-
cumference, calculated PWV may be
higher. We measured the distance from
the suprasternal notch to the femoral
pulse with a tape measure laid on the
body to use the most reproducible tech-
nique. Alternatives include a measure
over the body or intra-arterial measure-
ment of the artery using imaging tech-
niques. Measuring over the body was not
donetoavoidpotentialreproducibilityis-
sues. Imaging of the vascular segment to
obtain a measurement was not feasible.
Although other measurement techniques
may have altered the ﬁndings for PWV, it
is important to note that brachD and
AI75, techniques not requiring such a
measurement,showedasimilarpatternof
reduced difference in arterial stiffness by
diabetes type after adjustment for waist
circumference.
The cross-sectional design of this
study also limits our ability to conclude
which factors cause the development of
altered arterial stiffness in diabetic pa-
tients. Longitudinal studies of vascular
changes in diabetic patients are needed to
further understand the role of glycemic
control, blood pressure, and adiposity on
arterial stiffness over time.
Insummary,youthwithtype2diabe-
tes have signiﬁcantly worse arterial stiff-
ness measures than youth with type 1
diabetes, probably because of their pat-
terns of elevated blood pressure and cen-
tral adiposity. Increased central adiposity
and blood pressure levels are associated
with measures of arterial stiffness, inde-
pendent of diabetes type. Longitudinal
studies are needed to determine whether
increased arterial stiffness is an early sign
of future progression to CVD in youth
with diabetes. Further studies could po-
tentially delineate key modiﬁable CVD
risk factors and the utility of preventive
interventionstodecreasetheratesofCVD
in patients with youth-onset type 1 and
type 2 diabetes.
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